Llwytho...

Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different pro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Blood Med
Prif Awduron: Abou Zahr, Abdallah, Saad Aldin, Ehab, Komrokji, Rami S, Zeidan, Amer M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2014
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278786/
https://ncbi.nlm.nih.gov/pubmed/25565910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S50482
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!